📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Denison Pharmaceuticals

1.1 - Company Overview

Denison Pharmaceuticals Logo

Denison Pharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of turn-key formulation, manufacturing, packaging, and testing solutions for branded OTC, Rx, and cosmetic markets. Services include technical operations from concept to commercialization; commercial manufacturing in nine compounding suites up to 2,000 gallons; packaging on 16 high-speed lines for liquids, tubes, jars, and aerosols; cGMP analytical, microbiological, and stability labs; validation and USP Monograph testing; and formulation and reverse-engineering.

Products and services

  • Technical Operations: Engineers and scales formulations from initial concept to commercialization using specialized equipment and experienced teams, executing turn-key development across branded OTC, Rx, and cosmetic products
  • Commercial Manufacturing: Produces pharmaceutical products in nine dedicated compounding suites with capacities up to 2,000 gallons, supporting industrial-scale batch compounding
  • Packaging: Operates high-speed assembly systems with 16 lines for liquids, tubes, jars, and aerosols, handling diverse product formats at scale

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Denison Pharmaceuticals

PPD Logo

PPD

HQ: United States Website
  • Description: Provider of CRO services across multiple therapeutic areas, enabling accelerated innovation and drug development through patient-centered strategies and data analytics. Offerings include GMP laboratory and analytical services, Decentralized Clinical Trials, Accelerated Enrollment Solutions, Preclarus data integration tools, regulatory affairs services, and integrated clinical development consulting.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full PPD company profile →
Amador Bioscience Logo

Amador Bioscience

HQ: United States Website
  • Description: Provider of translational sciences, clinical pharmacology, bioanalysis, biomarker, and clinical research services to biopharmaceutical companies to support drug development. Offerings include immunoassays and cell-based assays for biomarkers and anti-drug antibodies, biometrics and pharmacometrics, regulatory affairs, and support for global clinical trials.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Amador Bioscience company profile →
AmbioPharm Logo

AmbioPharm

HQ: United States Website
  • Description: Provider of peptide manufacturing and development services, including GMP and non-GMP custom peptide synthesis via solid phase, solution phase, or hybrid processes. Manufactures active pharmaceutical ingredients and generic peptides, develops research-grade complex peptides, and offers analytical development and validation for HPLC/UPLC, serving pre-clinical, medicinal, and toxicology programs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full AmbioPharm company profile →
ProPharma Logo

ProPharma

HQ: United States Website
  • Description: Provider of independent, single-source regulatory, compliance, pharmacovigilance, and medical information services for pharmaceutical, biotechnology, and medical device companies; offering RCO custom solutions across the full product lifecycle, tailored MedTech solutions from concept to market, full-service Oncology CRO capabilities, global lifecycle solutions, and Prodigy technology to de-risk decision making and drive value.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ProPharma company profile →
Cognivia Logo

Cognivia

HQ: Belgium Website
  • Description: Provider of analytical tools and services to optimize and speed clinical development of novel medicines, including Placebell to reduce data variability by addressing placebo response and patient heterogeneity; Compl-AI to predict non-adherence and dropout risks to aid patient engagement; and an Expert Analysis Service to detect and explain clinical site variability and help adjust data for clearer study results.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cognivia company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Denison Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Denison Pharmaceuticals

2.2 - Growth funds investing in similar companies to Denison Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Denison Pharmaceuticals

4.2 - Public trading comparable groups for Denison Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Denison Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Denison Pharmaceuticals

What does Denison Pharmaceuticals do?

Denison Pharmaceuticals is a provider of turn-key formulation, manufacturing, packaging, and testing solutions for branded OTC, Rx, and cosmetic markets. Services include technical operations from concept to commercialization; commercial manufacturing in nine compounding suites up to 2,000 gallons; packaging on 16 high-speed lines for liquids, tubes, jars, and aerosols; cGMP analytical, microbiological, and stability labs; validation and USP Monograph testing; and formulation and reverse-engineering.

Who are Denison Pharmaceuticals's competitors?

Denison Pharmaceuticals's competitors and similar companies include PPD, Amador Bioscience, AmbioPharm, ProPharma, and Cognivia.

Where is Denison Pharmaceuticals headquartered?

Denison Pharmaceuticals is headquartered in United States.

How many employees does Denison Pharmaceuticals have?

Denison Pharmaceuticals has 1,000 employees 🔒.

When was Denison Pharmaceuticals founded?

Denison Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Denison Pharmaceuticals in?

Denison Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Denison Pharmaceuticals

Who are the top strategic acquirers in Denison Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Denison Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Denison Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Denison Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Denison Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Denison Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Denison Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Denison Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Denison Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Denison Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Denison Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Denison Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Denison Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Denison Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Denison Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Denison Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Denison Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Denison Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Denison Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Denison Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Denison Pharmaceuticals